1. Home
  2. ARTL vs ASTI Comparison

ARTL vs ASTI Comparison

Compare ARTL & ASTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTL
  • ASTI
  • Stock Information
  • Founded
  • ARTL 2011
  • ASTI 2005
  • Country
  • ARTL United States
  • ASTI United States
  • Employees
  • ARTL N/A
  • ASTI N/A
  • Industry
  • ARTL Biotechnology: Pharmaceutical Preparations
  • ASTI Semiconductors
  • Sector
  • ARTL Health Care
  • ASTI Technology
  • Exchange
  • ARTL Nasdaq
  • ASTI Nasdaq
  • Market Cap
  • ARTL 3.1M
  • ASTI 2.9M
  • IPO Year
  • ARTL N/A
  • ASTI N/A
  • Fundamental
  • Price
  • ARTL $5.31
  • ASTI $1.99
  • Analyst Decision
  • ARTL Buy
  • ASTI
  • Analyst Count
  • ARTL 2
  • ASTI 0
  • Target Price
  • ARTL $30.00
  • ASTI N/A
  • AVG Volume (30 Days)
  • ARTL 117.0K
  • ASTI 1.0M
  • Earning Date
  • ARTL 11-11-2025
  • ASTI 08-12-2025
  • Dividend Yield
  • ARTL N/A
  • ASTI N/A
  • EPS Growth
  • ARTL N/A
  • ASTI N/A
  • EPS
  • ARTL N/A
  • ASTI N/A
  • Revenue
  • ARTL N/A
  • ASTI $41,135.00
  • Revenue This Year
  • ARTL N/A
  • ASTI N/A
  • Revenue Next Year
  • ARTL N/A
  • ASTI N/A
  • P/E Ratio
  • ARTL N/A
  • ASTI N/A
  • Revenue Growth
  • ARTL N/A
  • ASTI N/A
  • 52 Week Low
  • ARTL $4.20
  • ASTI $1.10
  • 52 Week High
  • ARTL $28.60
  • ASTI $4.41
  • Technical
  • Relative Strength Index (RSI)
  • ARTL 31.35
  • ASTI 50.38
  • Support Level
  • ARTL $4.60
  • ASTI $1.77
  • Resistance Level
  • ARTL $4.70
  • ASTI $1.88
  • Average True Range (ATR)
  • ARTL 0.56
  • ASTI 0.18
  • MACD
  • ARTL -0.24
  • ASTI -0.02
  • Stochastic Oscillator
  • ARTL 20.94
  • ASTI 50.00

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About ASTI Ascent Solar Technologies Inc.

Ascent Solar Technologies Inc is engaged in the manufacturing, and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.

Share on Social Networks: